Ligandal Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Private

  • Employees
  • 12

Employees

  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 43

Ligandal General Information

Description

Developer of nanomedicine therapies designed to offer gene editing tools with non-viral nano-carriers to treat gene-related diseases. The company's therapies include peptide-based technologies for gene therapy, gene editing, regenerative medicine, immunotherapy, advanced antidote-vaccine technology genetic materials and gene-specific payloads with unprecedented precision at the cellular and sub-cellular levels, enabling the medical system to access cell and tissue-specific delivery of gene therapies.

Contact Information

Website
www.api.ligandal.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 399 Sands Street, Building 303
  • Suite 609, Brooklyn
  • New York, NY 11205
  • United States
+1 (650)
Primary Industry
Enterprise Systems (Healthcare)
Other Industries
Discovery Tools (Healthcare)
Vertical(s)
Nanotechnology, Artificial Intelligence & Machine Learning, HealthTech, Life Sciences
Corporate Office
  • 399 Sands Street, Building 303
  • Suite 609, Brooklyn
  • New York, NY 11205
  • United States
+1 (650)

Ligandal Timeline

2022202320242025
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Ligandal Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Later Stage VC 01-Oct-2024 Completed Generating Revenue
7. Later Stage VC 07-Feb-2023 Completed Generating Revenue
6. Seed Round 30-May-2022 Completed Generating Revenue
5. Accelerator/Incubator Completed Generating Revenue
4. Seed Round 07-Sep-2018 Completed Generating Revenue
3. Seed Round 02-Jul-2017 Completed Startup
2. Angel (individual) 04-Aug-2016 $331K $859K Completed Startup
1. Seed Round 21-Feb-2014 $528K $528K Completed Startup
To view Ligandal’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Ligandal Patents

  • 46

    Total Documents Applications and Grants

  • Total Patents Families

  • 4

    Granted

  • 33

    Pending

  • Expiring in next 12 mo

Ligandal Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-3218505-A1 Methods and compositions for large-scale conjugatable polymer and protein synthesis Pending 30-Apr-2021
AU-2022264944-A1 Methods and compositions for large-scale conjugatable polymer and protein synthesis Pending 30-Apr-2021
EP-4329931-A1 Methods and compositions for large-scale conjugatable polymer and protein synthesis Pending 30-Apr-2021
US-20240269640-A1 Methods and compositions for large-scale conjugatable polymer and protein synthesis Pending 30-Apr-2021
EP-4329931-A4 Methods and compositions for large-scale conjugatable polymer and protein synthesis Pending 30-Apr-2021 B01J19/0046
To view Ligandal’s complete patent history, request access »

Ligandal Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ligandal Investors (43)

Investor Name Investor Type Holding Investor Since Participating Rounds
Mana Industries Venture Capital Minority
Angel (individual)
Angel (individual)
Angel (individual)
Angel (individual)
You’re viewing 5 of 43 investors. Get the full list »

Ready to get started?

Request a free trial

Ligandal FAQs

  • When was Ligandal founded?

    Ligandal was founded in 2013.

  • Where is Ligandal headquartered?

    Ligandal is headquartered in New York, NY.

  • What is the size of Ligandal?

    Ligandal has 12 total employees.

  • What industry is Ligandal in?

    Ligandal’s primary industry is Enterprise Systems (Healthcare).

  • Is Ligandal a private or public company?

    Ligandal is a Private company.

  • What is Ligandal’s current revenue?

    The current revenue for Ligandal is .

  • How much funding has Ligandal raised over time?

    Ligandal has raised $9.2M.

  • Who are Ligandal’s investors?

    Mana Industries, , , , and are 5 of 43 investors who have invested in Ligandal.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »